Medicare Prescription Payment Plan Info

In August 2022, President Biden signed the Inflation Reduction Act of 2022 (P.L. 117-169) into law. The prescription drug law makes improvements to Medicare by expanding benefits, lowering drug costs, and improving the sustainability of the Medicare program for generations to come. It provides meaningful financial relief for millions of people by improving access to affordable treatments and strengthening Medicare, both now and in the long run.

Fact Sheet: Medicare Prescription Payment Plan Final Part One Guidance

Medicare Prescription Payment Plan: Final Part One Guidance on Select Topics, Implementation of Section 1860D-2 of the Social Security Act for 2025, and Response to Relevant Comments

Medicare Prescription Payment Plan Implementation Timeline 

Fact sheet

Final Part 2 Guidance

Updated implementation timeline

Updates

On July 16, 2024, CMS released the final part two guidance for the new Medicare Prescription Payment Plan after considering the public comments. This guidance primarily focuses on Part D enrollee education, outreach, and communications related to the Medicare Prescription Payment Plan.

This guidance builds on the final part 1 guidance, which focuses on operational requirements for the program, issued on February 29, 2024, and is accompanied by the release of the final Medicare Prescription Payment Plan model materials.

Click here to read the full Press Release.